| NCT06709014 | A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD | RECRUITING | PHASE3 | 2025-02-04 | 2028-06 | 2027-12 |
| NCT05686044 | A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD | COMPLETED | PHASE2, PHASE3 | 2023-04-01 | 2024-02-13 | 2024-02-13 |
| NCT05357989 | A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD | COMPLETED | PHASE3 | 2022-08-03 | 2023-12-04 | 2023-12-04 |
| NCT04524351 | Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients | COMPLETED | PHASE1, PHASE2 | 2020-08-14 | 2022-01-31 | 2021-08-16 |
| NCT02925650 | Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease | COMPLETED | PHASE1, PHASE2 | 2017-03-02 | 2021-12-31 | 2021-12-10 |
| NCT01072812 | Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment | TERMINATED | PHASE1 | 2010-02 | 2010-07 | 2010-07 |